HROW vs PATH
Harrow Health Inc (HROW) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported HROW revenue for 2024-12-31 was $199.6M. Net income was -$17.5M. Revenue was up 53.3% from 2023-12-31 to 2024-12-31. HROW currently screens at market cap $1.28B.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
HROW currently screens at market cap $1.28B. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the HROW and PATH stock pages for the full models.
Not investment advice.